Elizabeth E. Powell

20.2k total citations · 6 hit papers
213 papers, 13.8k citations indexed

About

Elizabeth E. Powell is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Elizabeth E. Powell has authored 213 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Epidemiology, 123 papers in Hepatology and 24 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Elizabeth E. Powell's work include Liver Disease Diagnosis and Treatment (126 papers), Liver Disease and Transplantation (81 papers) and Hepatitis C virus research (36 papers). Elizabeth E. Powell is often cited by papers focused on Liver Disease Diagnosis and Treatment (126 papers), Liver Disease and Transplantation (81 papers) and Hepatitis C virus research (36 papers). Elizabeth E. Powell collaborates with scholars based in Australia, United Kingdom and United States. Elizabeth E. Powell's co-authors include Andrew D. Clouston, Mary E. Rinella, Vincent Wai‐Sun Wong, Julie R. Jonsson, David M. Purdie, J. Searle, June W. Halliday, L. W. Powell, Graham Cooksley and Reginald G. Hanson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Elizabeth E. Powell

203 papers receiving 13.5k citations

Hit Papers

Non-alcoholic fatty liver... 1990 2026 2002 2014 2021 2009 1990 1995 1999 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Non-alcoholic fatty liver disease
    2021 1.8k citations Elizabeth E. Powell et al. profile →
  2. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
    2009 1.5k citations Elizabeth E. Powell et al. profile →
  3. The Natural History of Nonalcoholic Steatohepatitis: A Follow–Up Study of Forty–Two Patients for Up to 21 Years
    1990 1.2k citations Elizabeth E. Powell et al. profile →
  4. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus
    1995 583 citations Elizabeth E. Powell et al. profile →
  5. Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
    1999 541 citations Andrew D. Clouston, Elizabeth E. Powell et al. profile →
  6. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease
    2013 349 citations Richard Skoien, Elizabeth E. Powell et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Elizabeth E. Powell 9.3k 6.6k 2.5k 1.9k 1.8k 213 13.8k
Jacob George 11.6k 1.3× 6.4k 1.0× 4.1k 1.7× 1.9k 1.0× 2.0k 1.1× 275 15.4k
Manuel Romero‐Gómez 11.1k 1.2× 8.0k 1.2× 3.0k 1.2× 2.5k 1.3× 1.5k 0.8× 375 14.7k
Rocío López 8.6k 0.9× 4.0k 0.6× 2.7k 1.1× 6.5k 3.4× 1.9k 1.0× 570 18.0k
Flemming Bendtsen 8.0k 0.9× 6.5k 1.0× 1.3k 0.5× 4.1k 2.1× 1.2k 0.6× 340 12.1k
Frank Lammert 6.6k 0.7× 5.3k 0.8× 1.0k 0.4× 5.4k 2.8× 1.9k 1.0× 514 15.3k
George N. Ioannou 8.0k 0.9× 5.6k 0.9× 1.7k 0.7× 2.1k 1.1× 2.0k 1.1× 211 12.6k
Amedeo Lonardo 11.3k 1.2× 4.3k 0.7× 5.9k 2.4× 2.0k 1.0× 1.7k 0.9× 202 14.4k
Manal F. Abdelmalek 13.3k 1.4× 5.8k 0.9× 6.3k 2.6× 2.4k 1.2× 3.0k 1.6× 207 16.9k
Mark L. Van Natta 14.7k 1.6× 6.3k 1.0× 5.5k 2.2× 3.0k 1.6× 2.6k 1.4× 111 19.2k
Jörn M. Schattenberg 6.7k 0.7× 3.4k 0.5× 2.5k 1.0× 1.5k 0.8× 1.6k 0.9× 332 9.2k

Countries citing papers authored by Elizabeth E. Powell

Since Specialization
Citations

This map shows the geographic impact of Elizabeth E. Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth E. Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth E. Powell more than expected).

Fields of papers citing papers by Elizabeth E. Powell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth E. Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth E. Powell. The network helps show where Elizabeth E. Powell may publish in the future.

Co-authorship network of co-authors of Elizabeth E. Powell

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth E. Powell. A scholar is included among the top collaborators of Elizabeth E. Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth E. Powell. Elizabeth E. Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chaoyi, Quan Nguyen, Katharine M. Irvine, Elizabeth E. Powell, & Andrew D. Clouston. (2025). MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: Implications for assessing therapeutic response. Journal of Hepatology. 84(4). e135–e137.
2.
Radford‐Smith, Daniel, Alex M. Dickens, Matej Orešič, et al.. (2025). Progressive fibrosis in human MASLD is associated with spatially linked transcriptomic signatures of metabolic reprogramming and senescence. JHEP Reports. 8(2). 101657–101657. 1 indexed citations
3.
Powell, Elizabeth E., Günter Härtel, Richard Skoien, et al.. (2024). Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer. JGH Open. 8(7). e70000–e70000. 1 indexed citations
4.
Skoien, Richard, Günter Härtel, James O’Beirne, et al.. (2024). Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage study. Public Health. 232. 178–187. 1 indexed citations
5.
McPhail, Steven, Anthony Russell, James O’Beirne, et al.. (2024). An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations. Patient Preference and Adherence. Volume 18. 1845–1855.
6.
Senanayake, Sameera, Adrian Barnett, David Brain, et al.. (2024). A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia. Public Health. 228. 105–111. 4 indexed citations
7.
Keshvari, Sahar, Berit Genz, Melanie Caruso, et al.. (2022). Therapeutic potential of macrophage colony-stimulating factor in chronic liver disease. Disease Models & Mechanisms. 15(4). 8 indexed citations
8.
Shahid, Shaouli, Christina M. Bernardes, Maree Toombs, et al.. (2022). Partnering with support persons and clinicians to improve the health care experiences of patients with cirrhosis. Journal of Clinical Nursing. 32(11-12). 2559–2574. 5 indexed citations
9.
Hayward, Kelly L., Leigh U. Horsfall, Amy Johnson, et al.. (2021). Towards collaborative management of non‐alcoholic fatty liver disease: a ‘real‐world’ pathway for fibrosis risk assessment in primary care. Internal Medicine Journal. 52(10). 1749–1758. 5 indexed citations
10.
Valery, Patricia C., Steven McPhail, Katherine Stuart, et al.. (2020). Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis. Internal Medicine Journal. 51(5). 691–698. 17 indexed citations
11.
Williams, Suzanne, Laurence Britton, Steven McPhail, et al.. (2020). Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics. Hepatology Communications. 4(4). 518–526. 13 indexed citations
12.
Valery, Patricia C., Christina M. Bernardes, Katherine Stuart, et al.. (2020). <p>Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)</p>. Patient Preference and Adherence. Volume 14. 599–611. 17 indexed citations
13.
Hayward, Kelly L., Preya Patel, Patricia C. Valery, et al.. (2019). Medication‐Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention. Hepatology Communications. 3(5). 620–631. 35 indexed citations
14.
Hayward, Kelly L., Leigh U. Horsfall, Neil Cottrell, et al.. (2017). Optimising care of patients with chronic disease: patient‐oriented education may improve disease knowledge and self‐management. Internal Medicine Journal. 47(8). 952–955. 22 indexed citations
15.
Irvine, Katharine M., Andrew D. Clouston, Antje Blumenthal, & Elizabeth E. Powell. (2015). Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
16.
Wójcik, Kamila, Leigh U. Horsfall, Katharine M. Irvine, et al.. (2015). Patterns of service utilisation within hepatology clinics: high prevalence of advanced liver disease. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
17.
McPhail, Steven, Leigh U. Horsfall, Katharine M. Irvine, Kevin J. Fagan, & Elizabeth E. Powell. (2015). Economic consideration for reducing hospital presentations among patients with decompensated cirrhosis: not all presentations avoided can be considered equal. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
18.
Irvine, Katharine M., Leesa Wockner, Mihir Shanker, et al.. (2015). Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
19.
Hayward, Kelly L., Patricia C. Valery, Neil Cottrell, et al.. (2015). Discrepancies in the use of medications in patients with cirrhosis. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
20.
Fagan, Kevin J., Katharine M. Irvine, Amanda Bates, et al.. (2013). Assessment of alcohol histories obtained from patients with liver disease: Opportunities to improve early intervention. Queensland's institutional digital repository (The University of Queensland).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob George Breakdown of academic impact, for papers by Manuel Romero‐Gómez Breakdown of academic impact, for papers by Rocío López Breakdown of academic impact, for papers by Flemming Bendtsen Breakdown of academic impact, for papers by Frank Lammert Breakdown of academic impact, for papers by George N. Ioannou Breakdown of academic impact, for papers by Amedeo Lonardo Breakdown of academic impact, for papers by Manal F. Abdelmalek Breakdown of academic impact, for papers by Mark L. Van Natta Breakdown of academic impact, for papers by Jörn M. Schattenberg
Rankless by CCL
2026